Agents such as semaglutide and tirzepatide have demonstrated especially notable efficacy in this regard, further reinforcing the concept that targeted weight management can meaningfully influence cardiovascular outcomes
It may help improve skin texture, reduce the appearance of fine lines, and support overall skin rejuvenation by promoting natural repair processes
Safety in TRIUMPH-1 The safety profile was consistent with incretin-class therapies: Most common AEs (12 mg dose): - Nausea: 42.4% - Diarrhea: 32.0% - Constipation: 26.1% - Vomiting: 25.3% Dysesthesia (a sensory disturbance tingling, numbness) and urinary tract infections were reported in approximately 10% of patients on the highest doses, but were generally mild to moderate and mostly resolved during treatment
Oral weight loss medications are also preferred by people with a needle phobia or who dont feel confident self-administering an injection
Wysze dawki, okoo 5001000 mcg dziennie sugerowane przy powaniejszych kontuzjach mini, cigien czy w stanach zapalnych ukadu pokarmowego